☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Pfizer
Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2004-2023)
May 1, 2024
Pfizer’s BEQVEZ (fidanacogene elaparvovec-dzkt) Receives US FDA Approval for Adults with Hemophilia B
April 26, 2024
Pfizer Reports Results from P-III Trial of Abrysvo for Increased Risk for RSV Disease
April 9, 2024
Pfizer’s Emblaveo (aztreonam-avibactam) Receives Positive CHMP Opinion for the Treatment of Patients with Multidrug-Resistant Infe...
March 22, 2024
Pfizer’s Prevenar 20 Receives EC’s Approval for the Protection Against Pneumococcal Disease in Pediatric Population
March 14, 2024
Pfizer Reports P-III Study Results of Adcetris for Treating Diffuse Large B-cell Lymphoma (DLBCL)
March 13, 2024
Load more...
Back to Home